Predictors of unfavorable clinical outcomes of myocardial infarction complicated cardiogenic shock: results of single center retrospective study
Article Sidebar
Main Article Content
Abstract
The aim – to search for risk factors of adverse clinical outcome of acute myocardial infarction (AMI) complicated by cardiogenic shock (CS).
Materials and methods. In pilot retrospective study 1,292 consecutive patients with AMI treated by emergent percutaneous coronary intervention (PCI) in the reperfusion center of Zaitsev V.T. Institute for General and Emergency Surgery NAMS of Ukraine were selected. 54 out of 1292 patients (4.2 %) matched the Society for Cardiovascular Angiography and Interventions (SCAI) criteria of CS stage C and higher either on admission or during hospitalization.
Results and discussion. The overall hospital mortality in patients with CS due to AMI in our series was 59.3 %. Univariant analysis revealed that the age of 65 and higher, left ventricular ejection fraction < 40 %, a single-vessel coronary lesion, absence of concomitant chronic total occlusion (CTO), reperfusion deterioration and cardiac arrest were the only risk factors for hospital death in CS patients. The risk of CS progression was independently associated with anemic syndrome
(Hb < 118 g/l), chronic total occlusion, and multivessel coronary disease. In a multivariant logistic regression the preexisting LV EF < 40 %, single-vessel disease and absence of CTO were found as the independent predictors of hospital mortality in СS.
Conclusions. СS in patients with AMI still be a significant challenge even after successful PCI, associated with high in-hospital mortality (59.3 %). There is an unmet need for development and implementation of an adjusted registry-based national protocol for CS management in order to improve patient survival.
Article Details
Keywords:
References
Рекомендації Асоціації кардіологів України з діагностики та лікування хронічної серцевої недостатності / За ред. Л.Г. Воронкова // Укр. кардіол. журн.– 2018.– № 3.– С. 11–76.
Ahmad Y., Sen S., Shun-Shin M.J. et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis // JAMA Intern. Med.– 2015.– Vol. 175.– Р. 931–939. doi: https://doi.org/10.1001/jamainternmed.2015.0569.
Chesebro J.H., Knatterud G., Roberts R. et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge // Circulation.– 1987.– Vol. 76 (1).– Р. 142–154. doi: https://doi.org/10.1161/01.cir.76.1.142.
Baran D.A., Grines C.L., Bailey S. et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock // Catheter. Cardiovasc. Interv.– 2019.– Vol. 94.– Р. 29–37. doi: https://doi.org/10.1002/ccd.28329.
Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future // Eur. Heart J. Acute Cardiovasc. Care.– 2012.– Vol. 1 (1).– Р. 9–12. doi:https://doi.org/10.1177/2048872612438026.
Brilakis E.S., Mashayekhi K., Tsuchikane E. et al. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. A Global Expert Consensus Document // Circulation.– 2019.– Vol. 140.– Р. 420–433. doi: https://doi.org/10.1161/CIRCULATIONAHA.119.039797.
Guerchicoff A., Brener S.J., Maehara A. et al. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction) // JACC Cardiovasc. Interv.– 2014.– Vol. 7 (7).– Р. 733–740. doi: https://doi.org/10.1016/j.jcin.2014.01.166.
Harjola V.P., Lassus J., Sionis A. et al. CardShock Study Investigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock // Eur. J. Heart Fail.– 2015.– Vol. 17.– Р. 501–509. doi: https://doi.org/10.1002/ejhf.260.
Ibanez B., James S., Agewall S. et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) // Eur. Heart J.– 2018.– Vol. 39 (2).– Р. 119–177. doi: https://doi.org/10.1093/eurheartj/ehx393.
Jentzer J.C., van Diepen S., Barsness G.W. et al. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit // J. Am. Coll. Cardiol.– 2019.– Vol. 74 (17).– Р. 2117–2128. doi: https://doi.org/10.1016/j.jacc.2019.07.077.
Kolte D., Khera S., Aronow W.S. et al. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction in the United States // J. Am. Heart Assoc.– 2014.– Vol. 3.– Р. e000590. doi: https://doi.org/10.1161/JAHA.113.000590.
Mandawat A., Rao S.V. Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock // Circ. Cardiovasc. Interv. 2017.– Vol. 10.– Р. e004337. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.116.004337.
Mehta S.R., Wood D.A., Storey R.F. et al; COMPLETE Trial Steering Committee and Investigators. Complete Revascularization with Multivessel PCI for Myocardial Infarction // New Engl. J. Med.– 2019.– Vol. 381 (15).– Р. 1411–1421. doi: https://doi.org/10.1056/NEJMoa1907775.
Obling L., Frydland M., Hansen R. et al. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients // Eur. Heart J. Acute Cardiovasc. Care.– 2018.– Vol. 7 (1).– Р. 7–15. doi: https://doi.org/10.1177/2048872617706503.
Rathod K.S., Koganti S., Iqbal M.B. et al. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group // Eur. Heart J. Acute Cardiovasc. Care.– 2018.– Vol. 7 (1).– Р. 16–27. doi: https://doi.org/10.1177/2048872617741735.
Roffi M., Patrono C., Collet J.P. et al. ESC Scientific Document Group, 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) // Eur. Heart J.– 2016.– Vol. 37 (3).– Р. 267–315. doi: https://doi.org/10.1093/eurheartj/ehv320.
Schrage B., Dabboura S., Yan I. et al. Application of the SCAI classification in a cohort of patients with cardiogenic shock // Catheter. Cardiovasc. Interv.– 2020.– Jan 11. doi: https://doi.org/10.1002/ccd.28707.
Sleeper L.A., Reynolds H.R., White H.D. et al. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry // Am. Heart J.– 2010.– Vol. 160.– Р. 443–450. doi: https://doi.org/10.1016/j.ahj.2010.06.024.
Thiele H., Akin I., Sandri M. et al. for the CULPRIT-SHOCK Investigators: PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock // New Engl. J. Med.– 2017.– Vol. 377.– Р. 2419–2432. doi: https://doi.org/10.1056/NEJMoa1710261.
Thiele H., Ohman E.M., Desch S. et al. Management of cardiogenic shock // Eur. Heart J.– 2015.– Vol. 36.– Р. 1223–1230. doi:https://doi.org/10.1093/eurheartj/ehv051.
Thiele H., Zeymer U., Thelemann N. et al. Intra-aortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II Trial // Circulation.– – Vol. 139.– Р. 395–403. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.038201.
Thomas M.P., Bates E.R. Update on primary PCI for patients with STEMI // Trends. Cardiovasc. Med.– 2017.– Vol. 27 (2).– Р. 95–102. doi: https://doi.org/10.1016/j.tcm.2016.06.010.
Trost J.C., Hillis L.D. Intra-aortic balloon counterpulsation // Am. J. Cardiol.– 2006.– Vol. 97 (9).– P. 1391–1398.
Van Diepen S., Katz J.N., Albert N.M. et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association // Circulation.– 2017.– Vol. 136.– Р. e232-e268. doi: https://doi.org/10.1161/CIR.0000000000000525.
Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury // New Engl. J. Med.– 2007.– Vol. 357.– Р. 1121–1135. doi: https://doi.org/10.1056/NEJMra071667.